Home » Newsletters » BioWorld

BioWorld

March 2, 1992

View Archived Issues

FMP REACQUIRES SHARES IN AIDS UNIT

APPOINTMENTS AND ADVANCEMENTS

IMMUNE RESPONSE ADOPTS POISON PILL

CONJUGATED TREATMENT FOR BRAIN CANCER

1992 PUBLIC OFFERINGS NEAR $1 BILLION

BRITISH-BIO AIDS DRUG COMPLETES PHASE I

CELLPRO TECHNOLOGY IN GENE THERAPY TRIAL

GENDERM FILES INITIAL PUBLIC OFFERING

BIOCHEMICAL CHANGES IN ALZHEIMER'S

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...